Why Attend
Most enzymes found in nature are not suitable for industrial purposes. The field of protein and enzyme engineering is growing at a rapid rate, with competition within industries high and the need to optimise performance greater than ever.
Introducing the European Protein Engineering Congress, dedicated to uncovering the new and emerging practices, techniques and methods of protein and enzyme engineering across industries.
With pharmaceutical, flavour & fragrance, consumer goods, animal feed, and agrochemical sectors all approaching the design, build and generation of new biocatalysts and molecules not found in nature, come and learn from our line-up of leading speakers to get an update on the new technologies used in the field of strain and protein engineering.
Are you tasked with API and natural product synthesis? Why not hear how the industry is applying biosynthetic pathway transfer and multi-model assembly strategies to generate new molecules for industrial purposes?
Are you struggling to craft new enzymes never-before-seen in this century? Hear how ancestral sequence reconstruction, smart-library design, and computer-aided innovation can allow you to discover and generate new and stable active enzymes.
Attend and you'll be able to; increase your product pipeline, increase product efficiency and increase differentiation by meeting the experts in the biocatalysis and protein engineering space.
This is not your average protein engineering congress...it's about industry, sharing knowledge and optimising your protein engineering method for the best outcomes.
WHO WILL BE THERE
Following our hugely successful European Protein Degradation Congress, you can expect to meet:
The Speakers
Andreas Liese
Keith Mulholland
Keith was born in and grew up in Liverpool. He obtained his first degree in 1985 at the University of Manchester Institute of Science and Technology, followed by a PhD at the same institution working for Professor Dick Stoodley on C-Nucleoside Synthesis. A Post-Doctoral Fellowship at the University of Texas at Austin working for Professor Philip Magnus on Alkaloid synthesis followed.
He returned to the UK in 1990 to take up a position as a Medicinal Chemist at SmithKline Beecham Harlow working on Serotonin Antagonists for the treatment of Irritable Bowel Syndrome and Depression. In 1996 he moved to the Synthetic Chemistry Department and started work in the area of Process Development.
Following the merger of SmithKline Beecham and Glaxo-Wellcome in 2001, Keith moved to Process R&D AstraZeneca Macclesfield. In his time there he has held various roles. He was the Lead Chemist for the Olaparib project from 2006-2007 and the Catalysis Technology Leader from 2008 to 2011.
Since 2011 he has been the Associate Principal Scientist and Departmental Lead for Biocatalysis within Pharmaceutical Technology and Development.
Doru Roiban
Julien Hitce
Mike Salter
Mike Salter is a high level innovator and idea generator specialising in bridging the gap between academic research and translation of that research to create business opportunities.
Currently I work for AB Agri at Board level to identify new areas of innovation, drive innovation forward, co-ordinate research effort across different business units and identify sources of research funding via collaboration with other businesses and government funding bodies. I sit on the BBSRC/NERC SARIC funding panel as the AB Agri representative, the BBSRC Agriculture and Food Security Strategic Advisory Panel as an industrial advisor and the NERC Innovation Advisory Board as an industrial advisor.
Prior to AB Agri I was a key player in the establishment of a synthetic biology team being responsible for the design and management of a new build laboratory complex. This included the purchasing of capital equipment, managing the capital expenditure budget, initiating and managing health and safety policy for the team and managing biological safety.
I returned to commercial work following a 20 year period in academic research where I rose to the position of associate professor running an independent research group and teaching undergraduate and post graduate students. I am a specialist in molecular analysis techniques and have a number of significant publications from my research work.
Cyril Moccand
Helge Bode
Jörn Piel
Donald Hilvert
Reinhard Steiner
Bernhard Hauer
Helen Hailes
Helen received her Ph.D in 1991 at Cambridge under the supervision of Professor Jim Staunton. She pursued post-doctoral work at Cambridge, and then at Imperial College London with Professor Steve Ley and subsequently with Dr David Widdowson. She joined the Department of Chemistry, University College London as a Lecturer in 1994, becoming a Senior Lecturer in 2002, a Reader in 2005, and Professor of Chemical Biology in 2010.
Research is focused on the development of new sustainable chemistry approaches for use in synthesis. Several projects involve the discovery, optimisation and use of biocatalysts in single or multi-step pathways to construct single isomer biologically active molecules. In addition, we are investigating reactions and multi-step synthetic biology cascades in water and other green solvents.
Uwe Bornscheuer
Jennifer Littlechild
Jan von Langermann
Selin Kara
Dörte Rother
Manfred Reetz
Jason Micklefield
Kurt Faber
1973-1979 Studies of chemistry at the University of Graz.
1979 - 82 Thesis in synthetic organic chemistry at the University of Graz. Ph.D. in April 1982.
1982 - 1983: Post-doctoral fellowship at the Memorial University of Newfoundland. Synthesis of porphyrins.
1983 - 1989: University assistant at the Institute of Organic Chemistry, Graz University of Technology.
1990: Habilitation in Organic Chemistry at the Institute of Organic Chemistry, Graz University of Technology. Title: Biocatalytic Transformations.
October 1997, appointment to Associate Professor (C3) at Graz University of Technology.
September 1998, Full Professor at the Institute of Organic Chemistry, University of Graz (C4).
Visiting scientist / guest professor at:
University of Tokyo (1987/1988), Exeter University (1990), University of Trondheim (1994), Stockholm University (2001), University of Minneapolis (2005), ESPCI Paris (2010).
October 2017: Formal retirement, re-employed as senior scientist at the University of Graz.
Eric Eichhorn
Daniel Solis Escalante
Ditte Welner
Hans Iding
Jiří Damborský
Poster Session
Looking to showcase your recent work to the protein engineering community?
Our dedicated poster session is the perfect way to get your research noticed. In order to present a poster at the forum, you need to be registered as a delegate. Please note that there is limited space available and poster space is assigned on a first come first served basis (subject to checks and successful registration). At the congress, your presentation will be displayed in a dedicated poster area. The poster presentation will take place after the lunch break on day one.
Poster abstract submission deadline is on 16th September 2019. Abstracts received after this time may not be accepted to please submit you abstracts as soon as possible! Posters should be sized A0 (841mm x 1189mm) in portrait orientation.
For more information please contact [email protected] or [email protected]
Become a Sponsor
Kisaco Research provides the much needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.
Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.
With our extensive marketing experience and strategy, your partnership with Kisaco Research will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.
Find out more by calling us at +44 (0)20 3696 2920 or email us at partner@kisacoresearch.com.
Register interest
Download the agenda for the European Protein Engineering Congress:
Register your interest
Senior Event Partner
EnginZyme
Website: http://enginzyme.com/
Everything in nature is produced by enzymes performing reactions inside cells. EnginZyme’s technology platform converts these enzymes into an efficient easy to use catalysts to develop cost efficient enzyme processes to produce a range of chemicals and compounds suitable for pharma, agro, flavour &fragrance, food and chemicals industry. EnginZyme has developed a general enzyme immobilization support, EziG™, a high capacity carrier characterized by predictable, fast and easy immobilization of all enzyme types, without activity loss. When immobilising these enzymes on EziG, it is now possible to perform multi-step cascade reactions in flow in a single packed bed reactor. The EziG cascade cell-free synthetic biology technology is a versatile tool which can be employed to produce a broad range of valuable products, similarly to fermentation but with a more targeted process. Low capital and operating costs are achieved through enzyme reuse and flow operation of the highly active biocatalysts.
Conference Packages
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.
